Volume 13, Issue 3 pp. 270-272
RESEARCH LETTER

Increased DKA at presentation among newly diagnosed type 1 diabetes patients with or without COVID-19: Data from a multi-site surveillance registry

来自多监测点的数据:无论有没有新冠肺炎, 新发的1型糖尿病患者在就诊时DKA增加

Kara Beliard

Kara Beliard

Mount Sinai Kravis Children's Hospital, Icahn School of Medicine, New York, New York, USA

Co-first authors.Search for more papers by this author
Osagie Ebekozien

Corresponding Author

Osagie Ebekozien

T1D Exchange, Boston, Massachusetts, USA

Co-first authors.

Correspondence

Osagie Ebekozien, T1D Exchange, 11 Avenue De Lafayette, Boston, MA 02115.

Email: [email protected]

Search for more papers by this author
Carla Demeterco-Berggren

Carla Demeterco-Berggren

Rady Children's Hospital/University of California, San Diego, California, USA

Search for more papers by this author
Guy Todd Alonso

Guy Todd Alonso

Barbara Davis Center, University of Colorado, Aurora, Colorado, USA

Search for more papers by this author
Mary Pat Gallagher

Mary Pat Gallagher

Hassenfeld Children's Hospital at NYU Langone, New York, New York, USA

Search for more papers by this author
Mark Clements

Mark Clements

Children Mercy Hospital, Kansas City, Missouri, USA

Search for more papers by this author
Robert Rapaport

Robert Rapaport

Mount Sinai Kravis Children's Hospital, Icahn School of Medicine, New York, New York, USA

Search for more papers by this author
First published: 07 December 2020
Citations: 38

Graphical Abstract

Highlights

  • Our multicenter study reports a higher proportion of diabetic ketoacidosis presentation of over 60% in newly diagnosed patients with type 1 diabetes with or without confirmed coronavirus disease 2019 (COVID-19) at diagnosis.
  • This finding is suggestive of delays in seeking care during the COVID-19 pandemic.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.